147 related articles for article (PubMed ID: 14508176)
1. Use of activated recombinant Factor VII (NovoSeven) during neurosurgery.
Karadimov D; Binev K; Nachkov Y; Platikanov V
J Neurosurg Anesthesiol; 2003 Oct; 15(4):330-2. PubMed ID: 14508176
[TBL] [Abstract][Full Text] [Related]
2. Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients.
Felfernig M; Huepfl M
Clin Neurol Neurosurg; 2008 Mar; 110(3):227-32. PubMed ID: 18083302
[TBL] [Abstract][Full Text] [Related]
3. Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Mariani G; Konkle BA; Ingerslev J
Haemophilia; 2006 Jan; 12(1):19-27. PubMed ID: 16409171
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of recombinant-activated factor VII in neurocritical care.
Fewel ME; Park P
Neurocrit Care; 2004; 1(1):19-29. PubMed ID: 16174895
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
6. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
7. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
8. Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
Veldman A; Fischer D; Voigt B; Beyer PA; Schlösser R; Allendorf A; Kreuz W
Intensive Care Med; 2002 Nov; 28(11):1635-7. PubMed ID: 12415453
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Payne EM; Brett SJ; Laffan MA
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
[TBL] [Abstract][Full Text] [Related]
10. [New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?].
Skalski JH; Czapla J; Nadziakiewicz P; Kaczmarski J; Zembala M
Przegl Lek; 2002; 59(11):941-5. PubMed ID: 12715727
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant factor VII (NovoSeven) in intraoperative blood saving during neurosurgical treatment of the brain arteriovenous malformation].
Novak V; Petrović B; Calija B; Mitov L; Rancić Z
Vojnosanit Pregl; 2007 Feb; 64(2):151-4. PubMed ID: 17348469
[TBL] [Abstract][Full Text] [Related]
12. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
13. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.
DiDomenico RJ; Massad MG; Kpodonu J; Navarro RA; Geha AS
Chest; 2005 May; 127(5):1828-35. PubMed ID: 15888865
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.
Park P; Fewel ME; Garton HJ; Thompson BG; Hoff JT
Neurosurgery; 2003 Jul; 53(1):34-8; discussion 38-9. PubMed ID: 12823871
[TBL] [Abstract][Full Text] [Related]
15. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
16. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
[TBL] [Abstract][Full Text] [Related]
17. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Kessler C
Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa (Novoseven) as a hemostatic agent.
Hedner U
Semin Hematol; 2001 Oct; 38(4 Suppl 12):43-7. PubMed ID: 11735110
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII in paediatric cardiac surgery.
Egan JR; Lammi A; Schell DN; Gillis J; Nunn GR
Intensive Care Med; 2004 Apr; 30(4):682-5. PubMed ID: 14685661
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa: a review on its clinical use.
Franchini M
Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]